stockrowTeva Pharmaceutical Industries Ltd.
TEVA Healthcare Drug Manufacturers Specialty & Generic
Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.
- Revenue
- −1.90%
- EPS
- −47.2%
- Free cash flow
- −30.3%
- Total debt
- −0.43%
Quarter to September 2026, against a year earlier
Follow TEVA
Alert me
Teva Pharmaceutical Industries Ltd. (TEVA) Total debt
Teva Pharmaceutical Industries Ltd.'s total debt at the end of fiscal 2025 was $16.8B, down 5.49% from $17.8B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $16.7B. Over the past ten years it has ranged from $9.9B (fiscal 2015) to $35.8B (fiscal 2016); the current reading is higher than 18% of that period. Teva Pharmaceutical Industries Ltd. ranks 2nd of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $16.8B | (5.49%) |
| FY2024 | $17.8B | (10.34%) |
| FY2023 | $19.8B | (6.50%) |
| FY2022 | $21.2B | (7.95%) |
| FY2021 | $23.0B | (11.10%) |
| FY2020 | $25.9B | (3.67%) |
| FY2019 | $26.9B | (6.95%) |
| FY2018 | $28.9B | (10.96%) |
| FY2017 | $32.5B | (9.29%) |
| FY2016 | $35.8B | 260.05% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $16.7B | 0.76% |
| Jun 2026 | $16.6B | (0.21%) |
| Mar 2026 | $16.6B | (1.07%) |
| Dec 2025 | $16.8B | 0.10% |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| TAK Takeda Pharmaceutical Co. compare | $28.8B |
| TEVA Teva Pharmaceutical Industries Ltd. | $16.7B |
| HLN Haleon PLC Sponsored ADR compare | $11.1B |
| ZTS Zoetis Inc. compare | $9.0B |
| ELAN Elanco Animal Health Incorporated compare | $3.9B |
| VTRS Viatris Inc. compare | $1.7B |
| RDY Dr. Reddy's Laboratories Ltd compare | $753.0M |
| NBIX Neurocrine Biosciences, Inc. compare | $274.0M |
| UTHR United Therapeutics Corporation compare | $200.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on TEVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement